These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9418167)

  • 1. HIV infection in macrophage: role of long-lived cells and related therapeutical strategies.
    Aquaro S; Balestra E; Cenci A; Francesconi M; Caliò R; Perno CF
    J Biol Regul Homeost Agents; 1997; 11(1-2):69-73. PubMed ID: 9418167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of HIV dynamics and drug resistance in macrophages.
    Aquaro S; Caliò R; Balestra E; Bagnarelli P; Cenci A; Bertoli A; Tavazzi B; Di Pierro D; Francesconi M; Abdelahad D; Perno CF
    J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):23-7. PubMed ID: 9689575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies towards HIV-1 infection in macrophages.
    Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S
    Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
    Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
    J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanctuary sites in HIV-1 infection.
    Hoetelmans RM
    Antivir Ther; 1998; 3 Suppl 4():13-7. PubMed ID: 10723504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation between HIV-inhibiting drug activity in human macrophages and clinical outcome].
    Aquaro S; Balestra E; Panti S; Cenci A; Serra F; Francesconi M; Abdelahad D; Caliò R; Perno CF
    Clin Ter; 1998; 149(921):37-41. PubMed ID: 9621487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
    Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
    Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression.
    Magnani M; Balestra E; Fraternale A; Aquaro S; Paiardini M; Cervasi B; Casabianca A; Garaci E; Perno CF
    J Leukoc Biol; 2003 Nov; 74(5):764-71. PubMed ID: 12960277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophages: a crucial reservoir for human immunodeficiency virus in the body.
    Balestra E; Perno CF; Aquaro S; Panti S; Bertoli A; Piacentini M; Forbici F; D'Arrigo R; Calió R; Garaci E
    J Biol Regul Homeost Agents; 2001; 15(3):272-6. PubMed ID: 11693436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies.
    Demonté D; Quivy V; Colette Y; Van Lint C
    Biochem Pharmacol; 2004 Sep; 68(6):1231-8. PubMed ID: 15313421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.
    Aquaro S; Caliò R; Balzarini J; Bellocchi MC; Garaci E; Perno CF
    Antiviral Res; 2002 Aug; 55(2):209-25. PubMed ID: 12103427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
    Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
    J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus.
    Aquaro S; Bagnarelli P; Guenci T; De Luca A; Clementi M; Balestra E; Caliò R; Perno CF
    J Med Virol; 2002 Dec; 68(4):479-88. PubMed ID: 12376954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages--promise and peril.
    TreatmentUpdate; 1998 Dec; 10(10):4-5. PubMed ID: 11366018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maedi-visna virus and its relationship to human immunodeficiency virus.
    Thormar H
    AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
    Notermans DW; Danner SA; de Wolf F; Lange JM
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1909-12. PubMed ID: 9856176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV therapy in the post-eradication era.
    Vella S; Palmisano L
    J Biol Regul Homeost Agents; 2000; 14(1):34-7. PubMed ID: 10763890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.